223 related articles for article (PubMed ID: 18480336)
1. Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences.
Stabler RA; Dawson LF; Phua LTH; Wren BW
J Med Microbiol; 2008 Jun; 57(Pt 6):771-775. PubMed ID: 18480336
[TBL] [Abstract][Full Text] [Related]
2. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G
J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495
[TBL] [Abstract][Full Text] [Related]
3. Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities.
Quesada-Gómez C; López-Ureña D; Chumbler N; Kroh HK; Castro-Peña C; Rodríguez C; Orozco-Aguilar J; González-Camacho S; Rucavado A; Guzmán-Verri C; Lawley TD; Lacy DB; Chaves-Olarte E
Infect Immun; 2016 Jan; 84(3):856-65. PubMed ID: 26755157
[TBL] [Abstract][Full Text] [Related]
4. Sequence variation in tcdA and tcdB of Clostridium difficile: ST37 with truncated tcdA is a potential epidemic strain in China.
Du P; Cao B; Wang J; Li W; Jia H; Zhang W; Lu J; Li Z; Yu H; Chen C; Cheng Y
J Clin Microbiol; 2014 Sep; 52(9):3264-70. PubMed ID: 24958798
[TBL] [Abstract][Full Text] [Related]
5. Comparative biofilm-forming ability between
Morais MLGDS; Santos MGC; Costa CL; Martins CS; Leitão RFC; de Melo Pacífico D; Quesada-Gómez C; Castelo Branco D; Ferreira EO; Brito GAC
Front Cell Infect Microbiol; 2022; 12():1033698. PubMed ID: 36619751
[TBL] [Abstract][Full Text] [Related]
6. Phylogenomics of 8,839 Clostridioides difficile genomes reveals recombination-driven evolution and diversification of toxin A and B.
Mansfield MJ; Tremblay BJ; Zeng J; Wei X; Hodgins H; Worley J; Bry L; Dong M; Doxey AC
PLoS Pathog; 2020 Dec; 16(12):e1009181. PubMed ID: 33370413
[TBL] [Abstract][Full Text] [Related]
7. Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.
Murray R; Boyd D; Levett PN; Mulvey MR; Alfa MJ
BMC Infect Dis; 2009 Jun; 9():103. PubMed ID: 19558711
[TBL] [Abstract][Full Text] [Related]
8. Proteogenomic analysis of the Clostridium difficile exoproteome reveals a correlation between phylogenetic distribution and virulence potential.
Quesada-Gómez C; Murillo T; Arce G; Badilla-Lobo A; Castro-Peña C; Molina J; López-Ureña D; González-Camacho S; Lomonte B; Chacón-Díaz C; Rodríguez C; Chaves-Olarte E
Anaerobe; 2020 Apr; 62():102151. PubMed ID: 31945474
[TBL] [Abstract][Full Text] [Related]
9. Subtyping analysis reveals new variants and accelerated evolution of Clostridioides difficile toxin B.
Shen E; Zhu K; Li D; Pan Z; Luo Y; Bian Q; He L; Song X; Zhen Y; Jin D; Tao L
Commun Biol; 2020 Jul; 3(1):347. PubMed ID: 32620855
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.
Sirard S; Valiquette L; Fortier LC
J Clin Microbiol; 2011 Dec; 49(12):4040-6. PubMed ID: 21956985
[TBL] [Abstract][Full Text] [Related]
11. Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile.
Lanis JM; Barua S; Ballard JD
PLoS Pathog; 2010 Aug; 6(8):e1001061. PubMed ID: 20808849
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of pathogenicity locus (PaLoc) and tcdC genetic diversity among tcdA
Kodori M; Ghalavand Z; Yadegar A; Eslami G; Azimirad M; Krutova M; Abadi A; Zali MR
Anaerobe; 2020 Dec; 66():102294. PubMed ID: 33181348
[TBL] [Abstract][Full Text] [Related]
13. Toxin B is essential for virulence of Clostridium difficile.
Lyras D; O'Connor JR; Howarth PM; Sambol SP; Carter GP; Phumoonna T; Poon R; Adams V; Vedantam G; Johnson S; Gerding DN; Rood JI
Nature; 2009 Apr; 458(7242):1176-9. PubMed ID: 19252482
[TBL] [Abstract][Full Text] [Related]
14. TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm.
Bakker D; Smits WK; Kuijper EJ; Corver J
PLoS One; 2012; 7(8):e43247. PubMed ID: 22912837
[TBL] [Abstract][Full Text] [Related]
15. Designed Ankyrin Repeat Protein (DARPin) Neutralizers of TcdB from Clostridium difficile Ribotype 027.
Peng Z; Simeon R; Mitchell SB; Zhang J; Feng H; Chen Z
mSphere; 2019 Oct; 4(5):. PubMed ID: 31578248
[No Abstract] [Full Text] [Related]
16. Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile.
Aldape MJ; Packham AE; Nute DW; Bryant AE; Stevens DL
J Med Microbiol; 2013 May; 62(Pt 5):741-747. PubMed ID: 23429695
[TBL] [Abstract][Full Text] [Related]
17. Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.
Sambol SP; Merrigan MM; Lyerly D; Gerding DN; Johnson S
Infect Immun; 2000 Oct; 68(10):5480-7. PubMed ID: 10992443
[TBL] [Abstract][Full Text] [Related]
18. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran.
Doosti A; Mokhtari-Farsani A
Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
[TBL] [Abstract][Full Text] [Related]
20. A MLST Clade 2 Clostridium difficile strain with a variant TcdB induces severe inflammatory and oxidative response associated with mucosal disruption.
Costa CL; López-Ureña D; de Oliveira Assis T; Ribeiro RA; Silva RO; Rupnik M; Wilcox MH; de Carvalho AF; do Carmo AO; Dias AA; de Carvalho CB; Chaves-Olarte E; Rodríguez C; Quesada-Gómez C; de Castro Brito GA
Anaerobe; 2016 Aug; 40():76-84. PubMed ID: 27311833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]